International versions of the Menopause Rating Scale (MRS)

Lothar A J Heinemann, Peter Potthoff, Hermann P G Schneider, Lothar A J Heinemann, Peter Potthoff, Hermann P G Schneider

Abstract

Background: Symptom scales for aging women have clinically been used for years and the interest in measuring health-related quality of life (HRQoL) has increased in recent years. The Menopause Rating Scale (MRS) is a formally validated scale according to the requirements for quality of life instruments. The aim of this paper is to review the current state of the instrument particularly concerning versions of the scale in different languages.

Mrs versions available: The translations were performed following international methodological recommendations for the linguistic & cultural adaptation of HRQoL instruments. The first translation was done from the German original scale into English (UK & USA). The English version was used as the source language for the translations into French, Spanish, Swedish, Mexican/Argentine, Brazilian, Turkish, and Indonesian languages (attached as additional PDF files).

Conclusion: The MRS scale is obviously a valuable tool for assessing health related quality of life of women in the menopausal transition and is used worldwide. The currently available 9 language versions have been translated following international standards for the linguistic and cultural translation of quality of life scales. Assistance is offered to help interested parties in the translation process.

References

    1. Greene JG. Measuring the symptom dimension of quality of life: General and menopause-specific scales and their subscale structure. In: Schneider HPG, editor. Hormone replacement therapy and quality of life. The Parthenon Publishing Group. Boca Raton, London, New York, Washington; 2002. pp. 35–43.
    1. Schneider HPG, Behre HM. Contemporary evaluation of climacteric complaints: Its impact on quality of life. In: Schneider HPG, editor. Hormone replacement therapy and quality of life. The Parthenon Publishing Group. Boca Raton, London, New York, Washington; 2002. pp. 45–61.
    1. Kupperman HS, Blatt MHG, Wiesbader H, Filler W. Comparative clinical evaluation of estrogen preparations by the menopausal and amenorrhoea indices. J Clin Endocrinol. 1953;13:688–703.
    1. Kupperman HS, Wetchler BB, Blatt MHG. Contemporary therapy of the menopausal syndrome. JAMA. 1959;171:1627–1637.
    1. Potthoff P, Heinemann LAJ, Schneider HPG, Rosemeier HP, Hauser GA. Menopause-Rating Skala (MRS): Methodische Standardisierung in der deutschen Bevölkerung. Zentralbl Gynakol. 2000;122:280–286.
    1. Heinemann K, Assmann A, Möhner S, Schneider HPG, Heinemann LAJ. Reliabilität der Menopause-Rating-Skala (MRS). Untersuchung für die Deutsche Bevölkerung. Zentralbl Gynakol. 2002;124:161–163. doi: 10.1055/s-2002-32268.
    1. Schneider HPG, Heinemann LAJ, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): Reliability of scores of menopausal complaints. Climacteric. 2000;3:59–64.
    1. Schneider HPG, Heinemann LAJ, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): Comparison with Kupperman Index and Quality of Life Scale SF-36. Climacteric. 2000;3:50–58.
    1. Schneider HPG, Rosemeier HP, Schnitker J, Gerbsch S, Turck R. Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen®. Maturitas. 2000;37:113–124. doi: 10.1016/S0378-5122(00)00177-8.
    1. Schneider HPG, Heinemann LAJ, Thiele K. The Menopause Rating Scale (MRS): Cultural and linguistic translation into English. Life and Medical Science Online. 2002;3:DOI:101072/LO0305326.
    1. Anonymous Trust introduces new translation criteria. Medical Outcomes Trust Bulletin. 1997;5:2–4.
    1. Acquadro C, Jambon B, Ellis D, Marquis P. In Quality of Life and Pharmaco-Econonomics in Clinical Trials. 2. 1996. Languages and translation issues; pp. 575–585. Edited by B Spilker.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren